← Back to all trials
Not Yet Recruiting
NCT07278362
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
Conditions: Prostate Cancer, Hypogonadism, Male
Sex: Male
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE4
Enrollment: 35
Sponsor: University of Miami
Location: Desai Sethi Urology Institute Miami Florida
Summary
The purpose of this study is evaluate the safety of testosterone replacement therapy in men with newly diagnosed low-risk prostate cancer and hypogonadism on active surveillance.
Eligibility Criteria
Inclusion Criteria:
* Males aged ≥ 18 years old
* Newly diagnosed with low-risk prostate cancer initially confirmed by fusion guided prostate biopsy (transrectal or trans perineal) by multiparametric MRI, and had a second confirmatory biopsy within the last 12 months
* Males diagnosed with low-risk prostate cancer undergoing active surveillance
* Two confirmatory testosterone levels \
Source: ClinicalTrials.gov (NCT07278362). StuddyBuddy aggregates publicly available trial information.
